Offered by: Nemours Children's
A Multinational, Open-Label, Non-Controlled Trial on Safety, Efficacy and Pharmacokinetics of NNC 0129-0000-1003 in Previously Treated Pediatric Patients With Severe Hemophilia A (Pathfinder 5)
To evaluate a drug with patients with Hemophilia A.
Male patients less than 12 years of age with severe Hemophilia A that are currently receiving treatment with a Factor VIII product.
The study consists of a "main phase" and an "extension phase." The main phase will be approximately 26 weeks. After completing the main phase, your child might proceed into the extension phase. Physical exam and blood samples will be taken.
Nemours has a number of service regions. Selecting your region will help us show you the right contact information and the most relevant content for you.